CXCL12 Knock-out Enhances Leukemia Stem Cell Response to Combination Chemotherapy Plus Tyrosine Kinase Inhibition in Flt3-ITD Acute Myeloid Leukemia

Nick R Anderson(University of Alabama at Birmingham), Ravi Bhatia(University of Alabama at Birmingham), Amanda K Mullen(University of Alabama at Birmingham), Shaowei Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Mason W Harris(University of Alabama at Birmingham), Hui Li(Shanghai Stomatological Hospital), Andrew J. Paterson
Blood
November 4, 2020
10.1182/blood-2020-142579
Cited by 2

Related Papers

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|627
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
|Blood|2003|541
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
|Blood|2007|536
American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care
|Journal of Clinical Oncology|2013|473
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
|Journal of Clinical Oncology|2017|468